they must have seen our frustrations, let's hope they got it right
- Forums
- ASX - By Stock
- CYC
- Ann: Technegas Enters Final Six Month USFDA Review Cycle
CYC
cyclopharm limited
Add to My Watchlist
5.26%
!
90.0¢

Ann: Technegas Enters Final Six Month USFDA Review Cycle, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
90.0¢ |
Change
-0.050(5.26%) |
Mkt cap ! $100.0M |
Open | High | Low | Value | Volume |
95.0¢ | 97.0¢ | 90.0¢ | $50.70K | 54.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10839 | 90.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.0¢ | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10839 | 0.900 |
1 | 7000 | 0.895 |
2 | 6100 | 0.890 |
1 | 543 | 0.885 |
3 | 10000 | 0.880 |
Price($) | Vol. | No. |
---|---|---|
0.910 | 3000 | 1 |
0.915 | 8240 | 1 |
0.920 | 18574 | 2 |
0.930 | 543 | 1 |
0.940 | 2543 | 2 |
Last trade - 11.18am 26/06/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online